PSMA PET for Improving Prostate Cancer Diagnosis, Treatment, and Management - AUA Abstract Review

In this discussion, supported by Lantheus, E. David Crawford, MD, joins Philip J. Koo, MD, and David M. Albala, MD,  to present seven abstracts highlighting PMSA PET imaging and the future of prostate cancer management. From PSMA-targeted fluorophore for improved cancer visualization to PSMA testing prior to salvage radiation therapy, the presenters cover a range of topics demonstrating the utility of PSMA PET imaging.